Periodic boundary value problems for impulsive neutral differential equations with multi-deviation arguments

We develop the impulsive inequality and the classical lower and upper solutions, and establish the comparison principles. By using these results and the monotone iterative technique, we obtain the existence of solutions of periodic boundary value problems for a class of impulsive neutral differential equations with multi-deviation arguments. An example is given to demonstrate our main results. Mathematical subject classification: Primary: 34A37; Secondary: 34k10

MorphTE: Injecting Morphology in Tensorized Embeddings

In the era of deep learning, word embeddings are essential when dealing with text tasks. However, storing and accessing these embeddings requires a large amount of space. This is not conducive to the deployment of these models on resource-limited devices. Combining the powerful compression capability of tensor products, we propose a word embedding compression method with morphological augmentation, Morphologically-enhanced Tensorized Embeddings (MorphTE). A word consists of one or more morphemes, the smallest units that bear meaning or have a grammatical function. MorphTE represents a word embedding as an entangled form of its morpheme vectors via the tensor product, which injects prior semantic and grammatical knowledge into the learning of embeddings. Furthermore, the dimensionality of the morpheme vector and the number of morphemes are much smaller than those of words, which greatly reduces the parameters of the word embeddings. We conduct experiments on tasks such as machine translation and question answering. Experimental results on four translation datasets of different languages show that MorphTE can compress word embedding parameters by about 20 times without performance loss and significantly outperforms related embedding compression methods.Comment: 20 pages, 6 figures, 18 tables. Published at NeurIPS 202

Plasticity of DNA methylation in mouse T cell activation and differentiation

<p>Abstract</p> <p>Background</p> <p>Circulating CD4⁺T helper cells are activated through interactions with antigen presenting cells and undergo differentiation into specific T helper cell subsets depending on the type of antigen encountered. In addition, the relative composition of the circulating CD4⁺T cell population changes as animals mature with an increased percentage of the population being memory/effector type cells.</p> <p>Results</p> <p>Here, we report on the highly plastic nature of DNA methylation at the genome-wide level as T cells undergo activation, differentiation and aging. Of particular note were the findings that DNA demethylation occurred rapidly following T cell activation and that all differentiated T cell populations displayed lower levels of global methylation than the non-differentiated population. In addition, T cells from older mice had a reduced level of DNA methylation, most likely explained by the increase in the memory/effector cell fraction. Although significant genome-wide changes were observed, changes in DNA methylation at individual genes were restricted to specific cell types. Changes in the expression of enzymes involved in DNA methylation and demethylation reflect in most cases the changes observed in the genome-wide DNA methylation status.</p> <p>Conclusion</p> <p>We have demonstrated that DNA methylation is dynamic and flexible in CD4+ T cells and changes rapidly both in a genome-wide and in a targeted manner during T cell activation, differentiation. These changes are accompanied by parallel changes in the enzymatic complexes that have been implicated in DNA methylation and demethylation implying that the balance between these opposing activities may play a role in the maintaining the methylation profile of a given cell type but also allow flexibility in a cell population that needs to respond rapidly to environmental signals.</p

Characterizing HLA-A2-restricted CD8+ T-cell epitopes and immune responses to Omicron variants in SARS-CoV-2-inactivated vaccine recipients

IntroductionRecent surveillance has identified the emergence of the SARS-CoV-2 Omicron ariant, which exhibits the ability to evade multiple neutralizing antibodies generated by prior infection or vaccination. However, significant knowledge gaps remain regarding the CD8 T-cell immune reactivity to the Omicron variant. This study aims to evaluate the characteristics of HLA-A2-restricted CD8 T-cell epitopes from the Omicron variant and analyze epitope-specific CD8 T-cell responses to SARS-CoV-2 inactivated vaccines.MethodsWe conducted a comprehensive analysis of CD8 T-cell responses to SARS-CoV-2 inactivated vaccines, focusing on HLA-A2-restricted epitopes derived from the Omicron variant. Mutant epitopes were evaluated for their impact on antigen presentation and CD8 T-cell immune reactivity. Additionally, we screened for epitopes that exhibited reduced CD8 T-cell responses following the emergence of the Omicron variant.ResultsOur findings revealed that mutant epitopes in the Omicron variant led to escape from antigen presentation and diminished CD8 T-cell immune responses. We identified two epitopes associated with decreased CD8 T-cell reactivity post-Omicron variant emergence. Notably, we discovered an S protein epitope, 67A&gt;V, which demonstrated similar proportions of CD8 T-cell specificity between the ancestral and mutant strains, suggesting its conservation and potential immunogenicity for vaccine development. Furthermore, the third dose of the inactivated vaccine significantly increased the number of epitope-specific CD8 T cells, underscoring the importance of booster doses in enhancing cellular immune responses against the Omicron variant.DiscussionThis study highlights the ability of the Omicron variant to evade CD8 T-cell immune responses through epitope mutations, while also identifying conserved epitopes with potential utility in vaccine design. The observed increase in epitope-specific CD8 T cells following a booster dose emphasizes the critical role of additional vaccinations in strengthening cellular immunity against emerging SARS-CoV-2 variants. These findings provide valuable insights for the development of next-generation vaccines targeting conserved epitopes and optimizing booster strategies

Interfacial potassium induced enhanced Raman spectroscopy for single-crystal TiO2 Nanowhisker

Structural control and element doping are two popular strategies to produce semiconductors with surface enhanced Raman spectroscopy (SERS) properties. For TiO 2 based SERS substrates, maintaining a good crystallinity is critical to achieve excellent Raman scattering. At elevated temperatures (> 600 °C), the phase transition from anatase to rutile TiO 2 could result in a poor SERS performance. In this work, we report the successful synthesis of TiO 2 nanowhiskers with excellent SERS properties. The enhancement factor, an index of SERS performance, is 4.96 × 10 6 for methylene blue molecule detecting, with a detection sensitivity around 10 −7 mol·L −1. Characterizations, such as XRD, Raman, TEM, UV–vis and Zeta potential measurement, have been performed to decrypt structural and chemical characteristics of the newly synthesized TiO 2 nanowhiskers. The photo absorption onset of MB adsorbed TiO 2 nanowhiskers was similar to that of bare TiO 2 nanowhiskers. In addition, no new band was observed from the UV–vis of MB modified TiO 2 nanowhiskers. Both results suggest that the high enhancement factor cannot be explained by the charge-transfer mechanism. With the support of ab initio density functional theory calculations, we reveal that interfacial potassium is critical to maintain thermal stability of the anatase phase up to 900 °C. In addition, the deposition of potassium results in a negatively charged TiO 2 nanowhisker surface, which favors specific adsorption of methylene blue molecules and significantly improves SERS performance via the electrostatic adsorption effect

A critical role for hepatic protein arginine methyltransferase 1 isoform 2 in glycemic control

Appropriate control of hepatic gluconeogenesis is essential for the organismal survival upon prolonged fasting and maintaining systemic homeostasis under metabolic stress. Here, we show protein arginine methyltransferase 1 (PRMT1), a key enzyme that catalyzes the protein arginine methylation process, particularly the isoform encoded by Prmt1 variant 2 (PRMT1V2), is critical in regulating gluconeogenesis in the liver. Liver‐specific deletion of Prmt1 reduced gluconeogenic capacity in cultured hepatocytes and in the liver. Prmt1v2 was expressed at a higher level compared to Prmt1v1 in hepatic tissue and cells. Gain‐of‐function of PRMT1V2 clearly activated the gluconeogenic program in hepatocytes via interactions with PGC1α, a key transcriptional coactivator regulating gluconeogenesis, enhancing its activity via arginine methylation, while no effects of PRMT1V1 were observed. Similar stimulatory effects of PRMT1V2 in controlling gluconeogenesis were observed in human HepG2 cells. PRMT1, specifically PRMT1V2, was stabilized in fasted liver and hepatocytes treated with glucagon, in a PGC1α‐dependent manner. PRMT1, particularly Prmt1v2, was significantly induced in the liver of streptozocin‐induced type 1 diabetes and high fat diet‐induced type 2 diabetes mouse models and liver‐specific Prmt1 deficiency drastically ameliorated diabetic hyperglycemia. These findings reveal that PRMT1 modulates gluconeogenesis and mediates glucose homeostasis under physiological and pathological conditions, suggesting that deeper understanding how PRMT1 contributes to the coordinated efforts in glycemic control may ultimately present novel therapeutic strategies that counteracts hyperglycemia in disease settings.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/163465/10/fsb221018-sup-0005-FigS5.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/163465/9/fsb221018-sup-0001-FigS1.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/163465/8/fsb221018-sup-0003-FigS3.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/163465/7/fsb221018-sup-0008-FigS8.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/163465/6/fsb221018-sup-0002-FigS2.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/163465/5/fsb221018_am.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/163465/4/fsb221018.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/163465/3/fsb221018-sup-0007-FigS7.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/163465/2/fsb221018-sup-0006-FigS6.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/163465/1/fsb221018-sup-0004-FigS4.pd

Surface Adsorption-Mediated Ultrahigh Efficient Peptide Encapsulation with a Precise Ratiometric Control for Type 1 and 2 Diabetic Therapy

A surface adsorption strategy is developed to enable the engineering of microcomposites featured with ultrahigh loading capacity and precise ratiometric control of co-encapsulated peptides. In this strategy, peptide molecules (insulin, exenatide, and bivalirudin) are formulated into nanoparticles and their surface is decorated with carrier polymers. This polymer layer blocks the phase transfer of peptide nanoparticles from oil to water and, consequently, realizes ultrahigh peptide loading degree (up to 78.9%). After surface decoration, all three nanoparticles are expected to exhibit the properties of adsorbed polymer materials, which enables the co-encapsulation of insulin, exenatide, and bivalirudin with a precise ratiometric control. After solidification of this adsorbed polymer layer, the release of peptides is synchronously prolonged. With the help of encapsulation, insulin achieves 8 days of glycemic control in type 1 diabetic rats with one single injection. The co-delivery of insulin and exenatide (1:1) efficiently controls the glycemic level in type 2 diabetic rats for 8 days. Weekly administration of insulin and exenatide co-encapsulated microcomposite effectively reduces the weight gain and glycosylated hemoglobin level in type 2 diabetic rats. The surface adsorption strategy sets a new paradigm to improve the pharmacokinetic and pharmacological performance of peptides, especially for the combination of peptides.Peer reviewe

GLP-1 receptor agonists: exploration of transformation from metabolic regulation to multi-organ therapy

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes and obesity, have evolved into multi-organ potential therapeutics due to their pleiotropic effects beyond glycemic control. Mechanistically, GLP-1 signaling modulates immune and inflammatory pathways, regulates autophagy and pyroptosis, alleviates endoplasmic reticulum stress, and interacts with the gut microbiome. These pleiotropic effects provide a rationale for exploring their role in multiple organ systems. Clinical trials have demonstrated cardiovascular and renal protection, leading to additional approvals in high-risk populations. Early data also suggest potential benefits in liver disease, obstructive sleep apnea, chronic respiratory disorders, neurodegenerative and psychiatric conditions, reproductive dysfunction, obesity-associated cancers, and sepsis, although these remain investigational. Therefore, this review aims to synthesize the evidence on the mechanistic expansion of GLP-1RAs from metabolic regulators to systemic modulators of inflammation, autophagy, and organ protection, and explores their therapeutic repurposing across diseases

Clinical Study Intranasal Dexmedetomidine on Stress Hormones, Inflammatory Markers, and Postoperative Analgesia after Functional Endoscopic Sinus Surgery

Background. A strong ongoing intraoperative stress response can cause serious adverse reactions and affect the postoperative outcome. This study evaluated the effect of intranasally administered dexmedetomidine (DEX) in combination with local anesthesia (LA) on the relief of stress and the inflammatory response during functional endoscopic sinus surgery (FESS). Methods. Sixty patients undergoing FESS were randomly allocated to receive either intranasal DEX (DEX group) or intranasal saline (Placebo group) 1 h before surgery. Stress hormones, inflammatory markers, postoperative pain relief, hemodynamic variables, blood loss, surgical field quality, body movements, and satisfaction were assessed. Results. Plasma epinephrine, norepinephrine, and blood glucose levels were significantly lower in DEX group as were the plasma IL-6 and TNF-levels ( &lt; 0.05). The weighted areas under the curve (AUCw) of the VAS scores were also significantly lower in DEX group at 2-12 h after surgery ( &lt; 0.001). Furthermore, hemodynamic variables, blood loss, body movements, discomfort with hemostatic stuffing, surgical field quality, and satisfaction scores of patients and surgeons were significantly better ( &lt; 0.05) in DEX group. Conclusions. Patients receiving intranasal DEX with LA for FESS exhibited less perioperative stress and inflammatory response as well as better postoperative comfort with hemostatic stuffing and analgesia